Information Request
Primary IR Contact
For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To request information, please fill out and submit the form below: